Navigation Links
New Disinfection Technology Expected To Combat Deadly CRE Threat
Date:3/21/2013

SAN FRANCISCO, March 21, 2013 /PRNewswire/ -- San Francisco-based Medizone International (MZEI:OB) (MZEI:QB), announced today that its patented, peer-reviewed disinfection system is 'more than capable' of eliminating CRE from hospital and health care environments.

Medizone CEO Edwin Marshall stated, "Given the growing public, media and health sector interest in the emergence of CRE  (Carbapenem-resistant Enterobacteriaceae) in hospitals as a highly antibiotic resistant cause of hospital acquired infections (HAI), we felt that it was important to make public the anticipated effectiveness of AsepticSure with CRE."

Dr Michael E. Shannon M.A ., M.Sc., M.D. President and Director of Medical Affairs for Medizone, added, "Although we are not permitted to conduct research on extremely dangerous pathogens such as CRE, I can say unequivocally that we have absolutely no difficulty destroying all of its relatives including Klebsiella and E coli which are commonly cited as examples of Enterobacteriaceae.

"These bacteria are among the easiest for our AsepticSure system to eliminate in that when we achieve a 6 log (99.9999%) kill with MRSA we are usually looking at a 7 log kill for Klebsiella and E coli (99.99999%). I therefore have no doubt that CRE can be completely eradicated from any contaminated space using our AsepticSure system."

AsepticSure has recently been trialed successfully at Belleville General Hospital in Ontario, Canada, and is also the recipient of a prestigious WHO award for innovation.

For press information on Medizone International, please contact:
Bruce Smeaton , Investor Relations, Medizone International, Inc.
T: 001-415-331-0202    E: bruce@medizoneint.com

Medizone International, Inc. is engaged in initial production and sales of its modular design AsepticSure® Decontamination Systems. Decontamination to the sterilization standard of >6 log (99.9999%) is obtainable within hospitals, airlines, cruise ships, long term care facilities, food processing plants, clean room manufacturing facilities, schools and other critical infrastructure.

This Press Release may contain certain forward looking statements that could involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

For more information, visit: www.medizoneint.com


'/>"/>
SOURCE Medizone International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PDI Signs Agreement with HealthTrust for Surface Disinfection Products
2. ARAMARK Healthcare Offered Disinfection Robot Revolutionizes Hospital Sanitation Practices on The Doctors
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
5. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
6. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
7. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
8. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
9. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
10. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
11. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... Global NASH market report ... rise in obesity will fuel the demand for ... years. The NASH Market is growing at a ... of rising number of obesity among young population. ... with no FDA approved therapeutics. Antioxidants, anti-diabetic medications, ...
(Date:5/5/2016)... , May 5, 2016  Replikins Ltd. today reported initial promising results in animal ... Photo - http://photos.prnewswire.com/prnh/20160505/364345 ... ... ... of all Zika specimens recorded on Pubmed. The analysis identified the highest gene Replikin ...
(Date:5/5/2016)... , May 5, 2016  Endo International ... today announced that Brian Lortie , President, ... from his position upon the appointment of a ... led its U.S. Pharmaceuticals business with responsibility for ... and marketing, strategy and portfolio development, commercial operations, ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... Textile Exchange is excited to announce ... stakeholder review. The stakeholder review is an important opportunity for interested parties to give ... value to the wool industry., The RWS is intended to be a global benchmark ...
(Date:5/5/2016)... Diego, CA (PRWEB) , ... May 05, 2016 , ... ... dashboard and dedicated Twitter feed to cover the latest news and commentary at the ... through 10th. This meeting of the American Society of Cataract and Refractive Surgery and ...
(Date:5/5/2016)... ... 2016 , ... TLC Laser Eye Centers announced today that it has acquired ... now be called “Gordon Schanzlin New Vision Institute, a TLC Laser Eye Center.” ... to ensure that patients continue to receive the highest quality of care. In addition, ...
(Date:5/5/2016)... ... May 05, 2016 , ... Spring Fertility , ... IVF and with egg freezing, today announced the grand opening of its first ... fertility care, Spring Fertility offers both fertility preservation (egg, sperm, embryo, and testicular ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Seminars for Business Journalists , led by the Wharton School’s most prominent ... issues.  This one-day program at the Wharton School’s San Francisco campus will ...
Breaking Medicine News(10 mins):